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The purpose of this investigation was to study the hemodynande
correlates of exercise function in patients with primary pulmonary
hypertension and to further define the role of exercise testing in
the evaluation of these individuals
. Beta from the progressive
exercise tests and subsequent cardiac catheterization in 16 consec-
alive patients, aged 16,9 ± 10
.4 years (range 6 to 35), with
primary pulmonary hypertension were prospectively collected and
analyzed. Exercise capacity averaged 40 x 36% (range 0 to 117%)
of that predicted for age, height and gender .
Statistically significant correlations existed between exercise
capacity and t0 Imitatively measured hemodynamic variables
.
Mean right atria) pressure, a variable previously noted to be one
of the best predictors of survival in patients with primary pulmo •
Dyspnea is one of the earliest and most common clinical
features of primary pulmonary hypertension (1-4). Early in
the course of the disease, shortness of breath is noted only
during relatively vigorous exercise . Later, dyspnea becomes
progressive and occurs with even mild exertion . Eventually,
the patient's ability to exercise becomes severely limited
(2,3)
.
Although the exercise capacity of patients with pri-
mary pulmonary hypertension has been noted to roughly
parallel the severity of pulmonary vascular obstruction (5),
the exact relation between exercise performance and hemo-
dynamic variables measured at cardiac catheterization has
not been evaluated .
The purpose of this study was to prospectively determine
the relation between the clinical manifestations, cardiac
catheterizalion data and exercise capacity of patients with
primary pulmonary hypertension and to further establish the
role of exercise testing in the noninvasive assessment of
these patients.
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nary hypertension, correlated best with exercise capacity (r =
-0
.83, p < 0.0001). Exercise capacity >75% of the predicted
value identified the two patients who had a positive response to
acute pulmonary vasodilator drug testing . Poor exercise capacity
(<10% of the predicted value) Identified the three patients who
died during or soon after cardiac catheterizalion.
The ability of exercise leading to tdemlfy patients at high risk
for cardiac calbeleriration was superior to that of other nonlnva-
sive variables . Results of exercise testing may help guide decisions
regarding the optimal timing of heart-lung or single lung trans-
plantation
.
(J Am Coll Cadiot 1991 ;18:1 .38-44)
Methods
Study patients. The study group consisted of 16 consec-
utive patients with documented or suspected primary pul-
monary hypertension referred to Columbia Presbyterian
Medical Center between April 1987 and December 1989 for
cardiac catheterization and acute pulmonary vasodilator
drug testing . The patients ranged in age from 6 to 35 years
(mean 16.9 ± 10 .4) ; four were male and 12 female, Three
patients from two separate pedigrees had familial primary
pulmonary hypertension ; the remainder had sporadic pri-
mary pulmonary hypertension . None of these patients had
structural heart anomalies, evidence of pulmonary thrombo-
embolic phenomena (on the basis of ventilation-perfusion
scans) or significant parenchymal lung disease (on the basis
of chest X-ray study and pulmonary function tests) .
Eight patients were receiving no medication at the time of
the study . Eight others were maintained on one or more of
the following medications : digoxin, diuretic drugs, nifedi-
pine, warfarin and phenoxybenzamine . One woman received
supplemental oxygen and long-term intravenous prostacy-
din therapy .
One child with familial primary pulmonary hypertension
was asymptomatic at the time of the study (New York Heart
Association functional class 1), six patients had symptoms
corresponding to functional class II, four were in class 111
and five were in class IV
.
Exercise protocol. All patients performed a standard pro-
gressive bicycle ergometry test (6). They were instructed to
0775-11197M1lllxl.5n
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maintain a pedaling rate of 60 rpm . During an initial 3-min
warm-up work load, patients pedaled against 0 resistance .
The work load was then increased by increments of
20 Wlmin (10 W!'min for patients < 120 em in height or those
who by history had severely limited exercise capacity, or
both) until the 60-rpm rate could no longer be maintained .
The work load at which the 60-rpm pedaling rate could not
be maintained was defined as the patient's peak work load .
Exercise capacity . defined as the percent of predicted peak
work load achieved, was calculated using standard equations
(7,8).
Throughout the exercise test, each patient's heart rate
and electrocardiogram (ECG) were monitored on a Quinton
Status 1000 recorder . Oxygen saturation was monitored with
a Nellcor N200 pulse oximeter and blood pressure was
measured each minute with an appropriate-sized cuff.
Other noninvasive measurements . Before the exercise
test, each patient had a chest X-ray study . ECG (standard 2
leads and V 0 R) and two-dimensional and Doppler echocar-
diograms
. Cardiomegaly was diagnosed if the cardiothoeacic
ratio was >0.5 on a posteroanterior chest X-ray film . Right
ventricular strain was diagnosed according to the criteria of
Park and Guntheroth (9)
.
The echocardiographic method of
King et al. (10) was used to diagnose the presence of
posterior systolic bowing of the interventricular septum .
Doppler ultrasound was used to measure the pulmonary
acceleration time and to diagnose the presence of valvulur
regurgitation
.
Cardiac catheterization . Cardiac catheterization was per-
formed on each patient I or 2 days after exercise testing and
noninvasive studies . Digoxin and diuretic agents were with-
held on the day before catheterization . All patients were
premeditated with meperidine, promethazine and scopola-
mine . Five of the most symptomatic patients received sup-
plemental oxygen during cardiac catheterization .
Right-sided pressures were recorded wide a Swae-Gauz
catheter . In two patients, it was not possible to advance the
catheter into the pulmonary artery ; in these patients, right
ventricular systolic pressure was assumed to be equal to
systolic pulmonary artery pressure . In one of these patients,
left ventricular end-diastolic pressure was measured and
assumed to be roughly equivalent to the mean pulmonary
capillary wedge pressure . Systemic arterial pressure and
oxygen saturation were measured with an indwelling arterial
catheter . In 10 patients, cardiac output was determined by
the thermedilution method (mean of three measurements)
.
In six patients with severe tricuspid or pulmonary valve
regurgitation, or both, cardiac output was calculated with
the Fick equation . Standard equations were used to calculate
pulmonary vascular resistance, systemic vascular resistance
and stroke volume . All flow, volume and resistance mea-
surements were normalized for body surface area .
Drug testing . Fourteen of the 16 patients underwent
acute vasodilator drug testing with intravenous prostacyclin
during cardiac catheterization . Acute pulmonary vasoreac-
tivity was evaluated because empiric treatment with vasodi-
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Hers may be deleterious if given to patients with fixed
pulmonary vascular disease (I1
.12) . Nine of these patients
also underwent sub equent short-term testing with nifedi-
pvtc {oral or sublingual) and either intravenous prostaglandin
E, or phentolamrne, or both . Details of the vasodilator
test . .
., methods have been published previously (11)
.
Va .
sodilators were not administered to two patients who mani-
fested hemodynamic instability .
Statistical analysis . Statistical analyses were performed
with an Apple Macintosh computer using the StatView
statistics program !Abacus Concepts) . Univariate and mul-
tivariate analyses were used to examine the relation between
exercise capacity and each of tht hemodynamic variables
studied . Student's r test for paired samples was used to
analyze the patients' responses to vasodilators and Student's
unpaired t test to compare the hemodyuamics of subgroups
of patients with primary pulmonary hypertension . Fisher's
exact test was used to assess the ability of noninvasive
variables to identify patients at high risk during cardiac
catheterzation, Data arc presented as mean values
t SD .
Results
Exercise capacity data (Table 1. Fig . 1) . Four patients
could not exercise beyond the initial 0-resistance warm-up
period and were assigned an exercise capacity of 0% . The
exercise capacity of the remaining 12 patients ranged from
13% to 117% of the predicted value : 2 were able to exercise
to >75% of their predicted value . The exercise capacity of
the entire series of patients averaged 40 ± 36% of the
predicted capacity
. No complications occurred during the
exercise tests .
Baseline hemodynamic data (Table 1) . All patients had
moderate to severe pulmonary hypertension . Mean pulmo-
nary artery pressure was 59
t
t1 mm Hg and pulmonary
vascular resistance index averaged 26 ± 17 units.mc . Mean
right atrial pressure was mildly elevated (8 t 7 mm Hg) and
cardiac index was slightly below normal (2 .3
.
0 .9literslmin
per m')
. The average mean pulmonary capillary wedge
pressure was in the normal range (7 ± 5 mm Hg) ; it was
>10 mm Hg in two patients . Mean right atrial pressure and
pulmonary capillary wedge pressure in patients who had
received diuretic drugs did not differ from values in patients
who had not received diuretic therapy .
Correlation of exercise capacity and hemodynamic varia
.
bles (Tables 1 and 2)
. The strongest correlation by univariate
analysis was the negative relation between exercise capacity
and mean right atria] pressure (Fig
. 2) . Statistically signifi-
cant negative correlations also existed between exercise
capacity and pulmonary artery systolic, diastolic and mean
pressures . pulmonary vascular resistance, systemic vascular
resistance, the pulmonary/systemic vascular resistance ratio
and the ratio of the pulmonary to systemic systolic pressure .
A statistically significant positive correlation existed be-
tween exercise capacity and cardiac index and stroke vol-
ume index
. The relation between exercise capacity and mean
1740
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Table I . Baseline Hemodynamies and Exercise Capacity of 16 Patients With Primary Pulmonary Hypertension
'These three patient, died during or soon after cardiac cathcleriaarion . C1 = cardiac index ; Dias =diastolic: EC =exercise capacity : PAIAu = pulmonary
to systemic systolic pressure ratio ; PCWP= pulmonary capillary wedge pressure
: peed = predicted ; Pt= patient ; PVRI =pulmonary vascular resistance index ;
PVRJSVR = pulmonary to systemic vascular resistance ratio: RAP = right atrial pressure ; SVI = stroke volume index ; SVRI = systemic vascular resistance
index ;
Spa = systolic.
pulmonary capillary wedge pressure did not achieve statis-
tical significance .
When Jnoltivariate analysis was applied to the data, the
mean right atrial pressure and the pulmonary/systemic vas-
cular resistance ratio emerged as the only hemodynamic
variables independently related to exercise capacity (p <
0 .05) (Table 2),
Hemodynamic response to short-term prostacyclin admin-
istration (Table
3) .
Prostacyclin increased cardiac index and
decreased pulmonary and systemic vascular resistance in
each of the 14 patients studied . At the dose of prostacyclin
Figure 1. Distribution of exercise capacity values in 16 patients with
primary pulmonary hypertension .
9
e
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that resulted in the greatest decrease in pulmonary vascular
resistance, the deviations in these variables from baseline
values were highly significant (p < 0 .001) . In contrast, the
effect of prostacyclin on mean pulmonary artery pressure
and pulmonarylsystemic vascular resistance ratio varied
from patient to patient and the deviations from baseline did
not achieve statistical significance. Exercise capacity did not
correlate with prostacyclin-induced changes in any of these
variables
.
Two of the 14 patients studied were classified as vasodi-
lator responders, according to the criteria of Rich (3) (that is,
a22% decrease in pulmonary artery pressure associated
with ?36% decrease in pulmonary vascular resistance and a
decrease in the
pulmonary/systemic
vascular resistance ra-
Table 2 . Results of Univariate Analysis in 16 Patients
'Statistically significant correlation with exercise capacity by multivariate
analysis. PAP = pulmonary artery pressure ; other abbreviations as in Table 1 .
PI No .
Mean
RAP(ran
Hg)
Pulmonary Artery Pressure
PVRI
(unit, . 2)
SVRI
until,'m'- )
PVRISVR
PAJ60
CI
(literslmin
per m2)
SVI
Imilm')
PCWP
tman He)
EC
170 predl
Sys
Imm Hg)
Dot
Imm Hg)
Mean
Int. Hg)
I 1
11
25 50 21 31 0 .7 0.9 2.1 18 2 65
2 0.11 67 35 51 17 27 0.6 0.7 2.6 35 6 67
3 0 90 50 62 21 27 0.8 0.8 2.8
40 3
60
4 1
too
45
70
20 24 0.8 a.9 3.2 42 8 46
Ep 27 45 13 27 0 .5 0.6 2.8 35 5 75
6 15 W 35 50 26 37 0 .7 0.8 1.6
19 7
25
7 1
67 35 47
10 19 0 .3 0.5 4.3 31 3 69
8 II 93 40 60 25 33 0 .8 0.8 1.9 27 5 18
9 1 80 40 60 20 32 0 .6 0.6 2.8 31 4 54
10 10 104 - - - 61 - 0.8 1.3 20 4 IS
II 22 84 - - - 42 - 0 .7 1 .5 21 - I3
1? 56 22 34 8 24
0 .3 0 .6 3 .1 38 8 117
I3`
15 105 h0 R0 22 24 0 .9 0 .9 5 .1 29 5 0
Id 13 73 38 51 33 51 0 .6 0 .6 1 .3 IS 10 0
IS' 13 142 77 98 54 51 1 .1 L'? 1 .6 17 II 0
16' 17 125
50
75
68 80 0 .S 1 .0 1 .1 10 22 0
Mean
8 88 41 59 26 37 0.7 OB 2 .3 28 7 40
'_ SD 7 27 IS
17
17 17 0.2 0
.2
0 .9 10 3
36
r Value p Value
Mean RAP' -0.83 <0.0001
PAP. Sys -0.72 <0.005
PAP. Dine
-0.69
<0.0)
Mean PAP -0.73 <0.005
PVRI -0 .73 <0 .005
SVRI -0 .66 <0 .01
PVR/SVR' -0 .71 <0 .005
PAIAo -0 .59 <0 .05
CI 0 .65 <0 .0)
SVI 0 .78 <0 .001
PCWP -0 .42 NS
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Right Atria] Pressure (mm Hg)
Figure 2
. Regression plot of exercise capacity (EC) versus mean
right atrial pressure (RAP) in 16 patients with primary pulmonary
hypertension . (Two patients had right racial pressures of 13 mm He
and exercise capacities of 017, predicted.)
tio)
. None of the other patients displayed this capacity for
active selective pulmonary vasodilation . The two vasodila-
tor responders were the same patients whose exercise ca-
pacity was >75% of the predicted value (p < 0 .05) .
Comparisons between patients who could or could not
exercise (Table 4)
. The hemodynamic findings in the four
patients who were unable to exercise beyond the initial
0-resistance warm-up work load (Group II were compared
with those who could exercise beyond that level (Group Il) .
Group I patients tended to have a lower cardiac index and
higher resistance and filling pressure than did their counter-
parts in Group 11 .
During the initial phases of cardiac catheteriznrirnt, be-
fore the administration of angiographic medium or vasodila-
tors, two of the four patients in Group I developed hypoten-
sion and bradycardia associated with an acute severe
increase in pulmonary vascular resistance
. One of these
patients subsequently had a complete cardiopulmonary ar-
rest and died in the catheterization laboratory
. The condition
of the other patient was stabilized, and she was electively
intubated and transferred to the pediatric intensive care unit .
Her condition progressively deteriorated and she died 48 h
after cardiac catheterization . A third patient completed the
cardiac catheterization and short-term vasodilator drug test-
ing, but developed hypetension associated with a junctional
-s 25
Table S . Hemodynamic Data During Acute Pruslacyclin Administration in 14 Patients
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rhythm 16 h after cardiac catheterization . Despite aggressive
interventions. she died 24 h later, In each of these three
cases, postmortem examination confirmed the presence of
primary pulmonary hypertension with advanced pulmonary
vascular changes.
Hence, only one of the four patients who were unable to
exercise survived beyond the early postcardiac catheteriza-
tion period. In contrast, none of the 12 patients whose
exercise capacity was >10% of the predicted value (Group
III died or had a serious complication during cardiac cathe-
terization or pulmonary vasodilator drug testing . The inabil-
ity to exercise was therefore a sensitive (sensitivity 100%)
and specific (specificity 92%) predictor of mortality risk
during cardiac catheterization .
Comparison between exercise testing and other noninvasive
techniques with regard to the prediction of catheterization-
related death (Table 5) . The inability to exercise was the
best predictor of catheterization-related death (p < 0 .01).
New York Heart Association functional class IV categori-
zation also identified these patients (sensitivity 100%, spec-
ificity 83%, p < 0.05). No other noninvasive variable accu-
rately predicted death during cardiac catheterization .
Discussion
Predictive accuracy of poor exercise capacity in primary
pulmonary hypertension. Our results indicate that poor ex-
ercise capacity predicts severe hemodynamic
abnormalities .
as measured during cardiac catheterization, among patients
with primary pulmonary hypertension
. This observation is
consistent with past investigations, in a slightly older group
of patients, that have indicated an association between
hemodynamic aberrations and poor exercise function . In a
study of nine patients with pulmonary hypertension of
various origins. Janicki et al. (5) found that patients whose
puicronary vascular resistance was >1,000 dynes-s-em
-s
(1'_ .5 Woods units) had a lower maximal oxygen consump-
tion and could not exercise as long as patients whose
pulmonary vascular resistance was <1,000 dynes'scm -s.
The exercise capacity of the patients with pulmonary hyper-
tension was less than that of four patients with a normal
pulmonary artery pressure .
D'Alonzo et al
. (13) reported that maximal oxygen con-
sumption in a group of I1 patients with primary pulmonary
hypertension averaged 40% of the predicted value, a value
-Deviation from baseline smlolically sigmficant (p C (I. "PI),
Data prescnld as mean _ SD Image in parentheses) .
Abbreviations as in Table I .
CI'
Iliterslmin per m'I
Heart PAP
Imm (ten
PVRP
lumlrm=)
sVRI'
lanins'm'l PVwSVR
Value wish
pros-din 7 5
5
1 4
I I 6-7 .61
53 a 18
122-821
16 .6 12.6
13.1-511
216x85
(128-42.3)
0
.73
(0.2-1 .71
% of baseline cater 146 0 '-'-SF 95 0 205 4 68
1979 64 c 10> 108 5
33%
II137-IBWb)
159rr-153`)) 1777-9691 1537,81%) (571-168%)
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Table 4 . Comparison of Hcmodynarric Findings in Patients Who Could (Group 1) or Could Not (Group 11) Exercise
'p 1 0.05 vs . Group I . Ahbroviarinns at in Table I.
corresponding to the 40% of predicted exercise capacity
achieved by patients in our study
. They (13) also observed
that the patient's anaerobic threshold occurred at a much
lower oxygen consumption than that of normal control
subjects and that the anaerobic threshold correlated well
with maximal oxygen pulse (a rough noninvasive estimate of
maximal stroke volume) . However, no attempt was made to
correlate exercise capacity with invasively measured hemo-
dynamic variables . In a separate study of 10 patients with
primary and thromboembolic pulmonary hypertension,
D'Alonzo et al. (14) reported that changes in total pulmonary
resistance in response to an 8-week course of vasodilator
therapy correlated well with concomitant changes in maxi-
mal oxygen consumption and oxygen pulse . However, the
relation between exercise capacity and the absolute level of
total pulmonary resistance was not evaluated .
Correlation of exercise capacity and right atrial pressure .
In addition to supporting the results of previous investiga-
tors, our data prospectively quantified the relation between
exercise capacity and hemodysamics in patients with pri-
mary pulmonary hypertension . One of the key findings in our
analysis was the strong negative correlation between exer-
cise capacity and mean right atrial pressure
. Elevation of
mean right atria] pressure reflects right ventricular decom-
pensation in the presence of increased afterload imposed by
pulmonary vascular disease . Under these circumstances, the
ability of the right ventricle to adapt to the additional
hemodynamic demands of exercise is limited. This factor
appears to contribute significantly to the deterioration of the
patient's exercise capacity .
Earlier investigations (15-17) have found mean right atria[
pressure to be one of the best predictors of survival in
patients with primary pulmonary hypertension . The close
association between exercise capacity and right atrial pres-
sure documented in the current study suggests that exercise
testing data can be used to noninvasively estimate the life
expectancy of patients with primary pulmonary hyperten-
sion. This information could be used to help guide decisions
regarding the optimal timing for heart-lung or single lung
transplantation .
Correlation of exercise capacity and response to vasodilator
administration . Our data also provide information about the
relation between exercise function and the response to acute
IACC Vol. 18 . No . 7
vasodilator administration . In a normal subject, exercise is
associated with a large increase in pulmonary blood flow,
This increase is accommodated by recruitment of blood
vessels ordinarily closed at rest and by distension of blood
vessels already open
. Pulmonary artery and left atrial pres-
sures may increase, but the transpulmonary gradient re-
mains relatively constant; pulmonary vascular resistance,
therefore, decreases during exercise (18). The degree to
which these functions of the pulmonary vascular bed are
impaired varies among patients with primary pulmonary
hypertension (19) and may be a causal factor in the severity
of their symptoms. If the capacity to achieve pulmonary
vasodilation in response to pharmacologic agents corre-
sponds to the ability to lower pulmonary vascular resistance
during exercise, the exercise capacity of patients with pri-
mary pulmonary hypertension who respond favorably to
vasodilators should exceed that of patients who do not
possess this capacity .
Surprisingly, our data did not reveal a statistically signif-
icant association between exercise capacity and the decrease
in pulmonary vascular resistance in response to acute ad-
ministration of prostacyclin
. This paradox may be explained
by the fact that a decrease in pulmonary vascular resistance
was rarely associated with a significant decline in mean
pulmonary artery pressure or the pulmonary/systemic vas-
cular resistance ratio. Others (20) have noted that a poor
Table S . Noninvasive Variables Assessed for Their Ability to
Predict Catheterization-Related Death in 16 Patients'
Exercsetesting
Radiography
Inability to exercise (p < 0.01) Cardiomegaly on CXR
History Echocardiography
Syncope
Posterior systolic bowing of IVS
Chest pain
Tricuspid regurgitation
Functional class IV (p < 0 .05)
Pulmonary regurgitation
Physical examination
Pulmonary acceleration time
Tricuspid regurgitation Electracardiography
Pulmonary regurgitation RV strain pattern
Pulse oximelny
Rening roam air 0, sat
'p = NS unless otherwise indicated. CXR = chess X-ray film ; IVS =
interverlricular sepmm :02
sat = systemic arterial oxygen saturation : RV =
right ventricular .
Mean
HAP
(mm Hg)
Pulmunury Artery Pressure
SVRI
(unit, an') PVR/SVR PAIAn
CI
Ililerslmin
per met
SVI
(mOm)
PCWP
Imm Hgl
EC
1 i prod)
Sw Dia, Mean PVRI
Imm Hg) iron Hg) Iron flat (unit-2 )
Croup I In = 12)
Mean IS III 56 77 44 53 0.8 0.9 1 .0 16 12 0
SO 2 30 17 19 21 23 0.2 0.3 95 4 7 0
Error 11
In
= 41
Mean 6' 81' 35 . 52' 18' 32' 0.6 0.7 2 .5 32' 53'
SD 7 IS 9 II 6 II 0.2 0.1 0 .9 7 32
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correlation exists between survival and the magnitude of
acute vasodilator-induced decrease in pulmonary vascular
resistance and have questioned the clinical significance of a
decrease in pulmonary vascular resistance that is unaccom-
panied by a simultaneous decrease in the mean pulmonary
artery pressure or pulmonarylsystemic vascular resistance
ratio (3,11,20,2 1) . In light of these considerations
. the poor
correlation between exercise capacity and the prostacyclin-
induced decrease in pulmonary vascular resistance is under-
standable .
The two patients in this study who achieved the best
exercise test results (exercise capacity >75a, of the pre-
dicted value) were the only patients to manifest a positive
response to prostacyclin (that is
. ?22% decrease in mean
pulmonary artery pressure associated with ~36h decrease
in pulmonary vascular resistance and a decrease in the
pulmonarylsystemie vascular resistance ratio)
. This finding
once again emphasizes the clinical importance of the distinc-
tion between "active pulmonary vasodilation" and the non-
specific "passive pulmonary vasodilation" (that is . a de-
crease in pulmonary vascular resistance unaccompanied by
a decrease in pulmonary artery pressure and the pulmonary"
systemic vascular resistance ratio) manifested by the ma-
jority of patients with primary pulmonary hypertension
(3,11,18,21). Furthermore, patients who have had a positive
response to acute pulmonary vasodilator testing are more
likely to have a good clinical response to long-term oral
vasodilator therapy (11,21) . Therefore, we speculate that
exercise testing may assist in identifying the patients with
primary pulmonary hypertension who are most likely to
benefit from long-term vasodilator therapy .
Risk of cardiac eatheterization . Past studies (1,2,22 23)
have reported that patients with primary pulmonary hyper-
tension have a relatively high mortality risk during cardiac
catheterization
. The three deaths in our present series reem-
phasize the fragile nature of these patients. The National
Institutes of Health prospective study (4) of primary pulmo-
nary hypertension, however, reported no deaths during
cardiac catheterization in 187 patients . Our series differs
from that study in that many of our patients were referred for
acute vasodilator drug testing after having failed standard
treatment regimens . It is, therefore, likely that their vascular
disease was more advanced than that of the typical patient
with primary pulmonary hypertension at initial presentation .
This factor may account for some of the discrepancy be-
Pveen the National Institutes of Health study and our series .
The inability to exercise beyond the initial 0-resistance
warm-up work load emerged as a clinically useful variable in
the precatheterization assessment of patients with primary
pulmonary hypertension . This feature identified each of the
three patients who died during or soon after cardiac cathe-
terization . Patients who could exercise Inc example, those
whose exercise capacity was >IOO, of the predicted value)
tolerated catheterization without complication . No other
noninvasive variable identified the patients at greatest risk
RHODES ET AL.
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during cardiac catheterization with such a high degree of
sensitivity and specificity
.
Patients who were unable to exercise also tended to have
the most severe htmodynamic derangements
. Such patients
arc unlikely to have a positive response to conventional
vasodilators (3)
. Therefore . we believe that for the patient
with primary pulmonary hypertension and extremely limited
exercise capacity, the risk of cardiac catheterization out-
weighs the small chance that information derived from the
procedure would enable the patient's physician to devise an
effective conventional vasodilator regimen . Consequently,
we recommend that exercise capacity be assessed to help
identify patients for whom cardiac catheterization may be
inadvisable . Such patients should be considered for direct
referral for heart-lung or single lung transplantation on the
basis of noninvasive evaluation without cardiac catheteriza-
tion studies. The decision to accept the risk of cardiac
cathet^rization for the purpose of evaluating the effective-
ness of or initiating therapy with investigational vasodilating
agents (for example, continuous intravenous prostacyclin
i24]) should he made on an individual basis .
The results of exercise testing often confirm what is
suspected on the basis of clinical judgment . However. exer-
cise testing also allows qualitative clinical assessments to be
quantitated and standardized. Such a process may ultimately
prove to be useful to physicians who must concern them-
selves with the difficult issues relating to the care and study
of patients with primary pulmonary hypertension .
Conclusions
. The exercise capacity of patients with pri-
mary pulmonary hypertension correlates well with hemody-
namie variables routinely measured during cardiac catheter
iz..tion. Mean right atrial pressure is the hemodynamic
variable that correlates best with exercise capacity
. Patients
with primary pulmonary hypertension and severely limited
exercise capacity (that is . < 10% of the predicted value) are
at high risk for complications during cardiac catheterization .
Progressive bicycle ergometry is a safe procedure that can
accurately identify these patients, thereby permitting timely
consideration of alternative Treatment plans (for example,
transplantation without prior cardiac catheterization) . Con-
versely- an exercise capacity
>75%e
of the predicted value
may identify the subgroup of patients with primary pulmo-
nary hypertension capable of active pulmonary vasodilation ;
in past studies (11,21) such patients have been found to be
those most likely to benefit from long-term vasodilator
;herapy . Exercise testing, therefore . appears to be a useful
addition to the noninvasive evaluation of patients with
primary pulmonary hypertension
.
References
I . HaghertD .RuhnU.Pnemypulmonaryhypcrmmiae.aszvelysisot7l
as
. Meda,ee 1986:65:56-722 .
7 . WulcottG.BurchellHB.Brown ALJr.Pnnorypelmoneryhypmension .
Am 1 Med 1970:x9:70-9.
3 .
Rich 5 . Primary pulmonary hypertension . Prog Cardiovase Di, 1988 :71 :
205-38
.
1744
k (N)" nT
EXERCISE Ft~N
[ CTI()N IN
II'
M(INARY HYFE".NSION
M
2
10110415, 050100 KT . LXIR Ml . Fishmwl .AP . ENIR'he 00111, w
ro;nIo I, , wirh pulmonary oo 01101 11,10x . Am 405 Rcspir Ills
I914 .nY:S 9i-N ,
'
	
1J
'
.
., .
lk
.
iul Eoorciss T,A~ 3,d J . Ptibdd-
7~
1 N W& 17? .
8 . Casper UM . Weiler-RovnII D. Gas exchange response In e,verciIn in
"I
IWG. ll-RM Illimr., ECCN. [hi-a,,:Y-
foo is Medico : . 1917
:60
.
I0 . Knrp 11
H, 6,1111,11 A, Ulal .. 1, W,,,, WE. I,"
CmW. MWO-75
.
It. 1-1 RJ . induced pulmonary vasudilelion in children
hyped-on.
and youm aduhs wish primary pulmonary
a
Chel 1515F5
497-5113 .
WK N . Win N, nM M Adverse hcm)d!namicamd clir
1121,
13. D AI ... GE. Cii..Ili L hil RL . dal . Comparison M progressive
pulmonary hypertension . Che51 1917:93:57-62
14. D Abu
. GE
. Gimml: L. D-Ae, DR. Noninvasive aoessmenl o.`
JACC Vol . In, Na. 7
=
d=:w-- d,
-nI
v,.,
.d`"-r
Therapy
11i "~
eR P
.
D,., ' M. ., -111.
C 'n %n
`2""' i
. .,i .
"
. Mod 9M
.11.1114.
16 . Glanvl110 .4R . Burke CM17, Theodore 1
. Robin ED . I,
4 .,
survival in pi
.
Primary pnlmonary
plan'allan Chest 155:91 :075-11.
I DW.
=L,,h r1l."11, .
Darsan CA. Pulmonary vascular
.A P. Id . The '11111 Circulation. Philadelphia : University d lp.,Zl
nia Press, 19'10 :41-55,
19 . Wil h- .. Sd k. S. Soldo.h- B.
Polio
S, V . ... E . W.,k.
L pi -ry emboli-
Medicine 1963 :42:335-55.
20 R
VII Levy PI Thel,,, , " ,,~,~diht., therapy the
'1~
hym.M,
Cl,
culation I001rIl :1191..1 .
i
Levy "
R""
-
primary pulmonary
of
.n Am
the
47 i~
22 . Celdini P, Genslri DR. HoOman SOS . Primary pulmonary hypertension
21 Noble
1..T,,,, ,
pulmonary
4
